Pfizer Inc (PFE)
31 Aug 2015
BRUSSELS, Aug 18 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:
LONDON - Baxalta wants Shire to improve on its $30 billion bid significantly before it will engage in talks, while its Dublin-based rival could sweeten its offer if it gets to see the U.S. biotech company's books, according to sources on both sides.
- A Manhattan federal judge has awarded plaintiffs' attorneys in a securities class action against drugmaker Pfizer Inc over off-label marketing more than $67 million in fees and expenses from a $400 million settlement reached in January.
* Baxalta CEO says can get to Shire bid value on its own (Adds Baxalta CEO comments, paragraphs 4, 13 and 14)
LONDON, Aug 10 - Shire Chief Executive Flemming Ornskov is stepping up his campaign to get Baxalta to the negotiating table as he pushes the benefits a $30 billion takeover offer to the U.S. biotech company's shareholders.
Aug 7 - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
Britain's competition watchdog has accused Pfizer and Flynn Pharma of breaching UK and European law by ramping up the cost of an epilepsy drug, given to more than 50,000 British patients, by as much as 2,600 percent.
* Pfizer says drug had previously been unprofitable (Adds Pfizer comment on drug's profitability)
BRUSSELS, Aug 5 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:
BRUSSELS - U.S. drugmaker Pfizer gained European Union antitrust approval on Tuesday for its proposed $15 billion acquisition of U.S. rival Hospira after pledging to sell some drugs to allay competition concerns.
|Johnson & Johnson (JNJ.N)||$94.75||-0.42|
|Novartis AG (NOVN.VX)||CHF94.35||+0.15|
|Merck & Co., Inc. (MRK.N)||$54.06||-1.31|
|Roche Holding Ltd. (ROG.VX)||CHF262.60||-0.60|
|Abbott Laboratories (ABT.N)||$45.98||-0.04|
|Bayer AG (BAYGn.DE)||€120.90||-0.60|
|Bayer AG (BAYE.F)||--||--|
|Sanofi SA (SASY.PA)||€88.02||-0.42|
|AstraZeneca plc (AZN.L)||4,120.00p||+36.00|
|GlaxoSmithKline plc (GSK.L)||1,340.50p||+9.50|
Earnings vs. Estimates
Analyst Research Reports
Trading Report for (PFE). A detailed report, including free correlated market analysis, and updates.
Provider : Stock Traders Daily
Provider : Wright Reports
Provider : New Constructs, LLC
Provider : ValuEngine, Inc.
Provider : S&P Capital IQ – STARS Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.